Mesa Laboratories MLAB Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Mesa Laboratories in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The official record: Mesa Laboratories’s 10-K, filed June 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mesa Laboratories's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Mesa Laboratories's cash & equivalents?
- Mesa Laboratories (MLAB) reported cash & equivalents of $26.93M in Q1 2026.
- How has Mesa Laboratories's cash & equivalents changed year-over-year?
- Mesa Laboratories's cash & equivalents decreased by 1.4% year-over-year, from $27.32M to $26.93M.
- What is the long-term trend for Mesa Laboratories's cash & equivalents?
- Over 3 years (2021 to 2026), Mesa Laboratories's cash & equivalents has grown at a -53.3% compound annual growth rate (CAGR), from $263.87M to $26.93M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.